GILEAD SCIENCES, INC. (GILD): SEC Filings & AI Analysis
Health Care. Latest 10-K, 10-Q, and 8-K filings for GILEAD SCIENCES, INC. (GILD) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 10-Q filed August 6, 2026: NEUTRAL Concern level: ELEVATED.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is GILEAD SCIENCES, INC. (GILD)?
GILEAD SCIENCES, INC. is a publicly traded company in the Health Care space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are GILD's most recent SEC filings?
Recent filings: 10-Q (August 6, 2026), 8-K (August 4, 2026), 8-K (May 20, 2026), 8-K (May 7, 2026), 10-Q (May 7, 2026).
What does GILD's latest filing analysis show?
GILD's most recent 10-Q (August 6, 2026) is rated NEUTRAL, concern level ELEVATED.
What is the 30-day outlook for GILD?
Based on GILD's latest filing, the model projects it will perform roughly in line with the S&P 500 over the next 30 days. This is model analysis for research, not investment advice.
Is GILD a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For GILEAD SCIENCES, INC. (GILD), its latest 10-Q is rated ELEVATED concern and the model projects it will perform roughly in line with the S&P 500 over 30 days. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Recent GILD filings analyzed
Compare across the sector: Health Care sector analysis →
Other Health Care companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- August 6, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading GILD snapshot...
Fetching live market data